<DOC>
	<DOCNO>NCT00949884</DOCNO>
	<brief_summary>This study evaluate efficacy safety FDA approve blood pressure medication olmesartan medoxomil compare FDA approve medication losartan potassium .</brief_summary>
	<brief_title>Olmesartan Comparison Losartan Hypertensive Subjects</brief_title>
	<detailed_description />
	<mesh_term>Olmesartan</mesh_term>
	<mesh_term>Olmesartan Medoxomil</mesh_term>
	<mesh_term>Losartan</mesh_term>
	<criteria>Males female age &gt; 18 year institutionalize sign informed consent . Mean cuff seat diastolic blood pressure ( BP ) must &gt; 95 mmHg &lt; 115 mmHg mean cuff seat systolic BP must &lt; 180 mmHg measure two consecutive qualification study visit placebo runin phase . The difference mean cuff seat diastolic BP must &lt; 7 mmHg two consecutive qualification study visit placebo runin phase . Subjects type 2 diabetes mellitus HbA1c â‰¥ 9.5 % Screening . Subjects serious disorder may limit ability evaluate efficacy safety olmesartan medoxomil losartan potassium , include cardiovascular , renal ( include absence one kidney ) , pulmonary , hepatic , gastrointestinal ( include clinically significant malabsorption ) , endocrine/metabolic ( exception noninsulin , dependent type 2 diabetes mellitus HbA1c &lt; 9.5 % Screening ) , hematologic/oncologic ( include active malignancy basal cell carcinoma ) , neurologic psychiatric disease . Subjects history myocardial infarction , angina , coronary angioplasty , bypass surgery heart failure within last 12 month . Subjects history New York Heart Association Class III IV congestive heart failure ( CHF ) . A history New York Heart Association Class I II CHF may exclusionary discretion Investigator . Subjects history cerebrovascular accident transient ischemic attack within last 1 year . Subjects clinically significant cardiac conduction defect , include second third degree atrioventricular ( AV ) block , leave bundle branch block , sick sinus syndrome , atrial fibrillation , atrial flutter , accessory bypass tract , arrhythmia require medication .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2011</verification_date>
</DOC>